|
1
|
Liu W, Gao Q, Chen K, Xue X, Li M, Chen Q,
Zhu G and Gao Y: Hiwi facilitates chemoresistance as a cancer stem
cell marker in cervical cancer. Oncol Rep. 32:1853–1860. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yee GP, de Souza P and Khachigian LM:
Current and potential treatments for cervical cancer. Curr Cancer
Drug Targets. 13:205–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scatchard K, Forrest JL, Flubacher M,
Cornes P and Williams C: Chemotherapy for metastatic and recurrent
cervical cancer. Cochrane Database Syst Rev.
10:CD0064692012.PubMed/NCBI
|
|
5
|
Gabrielli B, Bokhari F, Ranall MV, Oo ZY,
Stevenson AJ, Wang W, Murrell M, Shaikh M, Fallaha S, Clarke D, et
al: Aurora A is critical for survival in HPV-transformed cervical
cancer. Mol Cancer Ther. 14:2753–2761. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tabrizi SN, Brotherton JM, Kaldor JM,
Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S,
Cummins E, et al: Assessment of herd immunity and cross-protection
after a human papillomavirus vaccination programme in Australia: A
repeat cross-sectional study. Lancet Infect Dis. 14:958–966. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bosch FX, Burchell AN, Schiffman M,
Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK and
Muñoz N: Epidemiology and natural history of human papillomavirus
infections and type-specific implications in cervical neoplasia.
Vaccine. 26 Suppl 10:K1–K16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ndiaye C, Mena M, Alemany L, Arbyn M,
Castellsagué X, Laporte L, Bosch FX, de Sanjosé S and Trottier H:
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck
cancers: A systematic review and meta-analysis. Lancet Oncol.
15:1319–1331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doorbar J, Egawa N, Griffin H, Kranjec C
and Murakami I: Human papillomavirus molecular biology and disease
association. Rev Med Virol. 25 Suppl 1:S2–S23. 2015. View Article : Google Scholar
|
|
10
|
Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu
S, Li Y, Wang L, Liu Y, Yin P, et al: Cause-specific mortality for
240 causes in China during 1990–2013: A systematic subnational
analysis for the Global Burden of Disease Study 2013. Lancet.
387:251–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Becker FF and Broome JD: L-asparaginase:
Inhibition of early mitosis in regenerating rat liver. Science.
156:1602–1603. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rigouin C, Nguyen HA, Schalk AM and Lavie
A: Discovery of human-like L-asparaginases with potential clinical
use by directed evolution. Sci Rep. 7:102242017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shrivastava A, Khan AA, Khurshid M, Kalam
MA, Jain SK and Singhal PK: Recent developments in L-asparaginase
discovery and its potential as anticancer agent. Crit Rev Oncol
Hematol. 100:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Den Boer ML, van Slegtenhorst M, De
Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, Van Zutven LJ,
Beverloo HB, Van der Spek PJ, Escherich G, et al: A subtype of
childhood acute lymphoblastic leukaemia with poor treatment
outcome: A genome-wide classification study. Lancet Oncol.
10:125–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edqvist PH, Huvila J, Forsström B, Talve
L, Carpén O, Salvesen HB, Krakstad C, Grénman S, Johannesson H,
Ljungqvist O, et al: Loss of ASRGL1 expression is an independent
biomarker for disease-specific survival in endometrioid endometrial
carcinoma. Gynecol Oncol. 137:529–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fonnes T, Berg HF, Bredholt T, Edqvist PD,
Sortland K, Berg A, Salvesen HB, Akslen LA, Werner HMJ, Trovik J,
et al: Asparaginase-like protein 1 is an independent prognostic
marker in primary endometrial cancer, and is frequently lost in
metastatic lesions. Gynecol Oncol. 148:197–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Evtimova V, Zeillinger R, Kaul S and
Weidle UH: Identification of crash, a gene deregulated in
gynecological tumors. Int J Oncol. 24:33–41. 2004.PubMed/NCBI
|
|
18
|
Weidle UH, Evtimova V, Alberti S, Guerra
E, Fersis N and Kaul S: Cell growth stimulation by CRASH, an
asparaginase-like protein overexpressed in human tumors and
metastatic breast cancers. Anticancer Res. 29:951–963.
2009.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lois C, Hong EJ, Pease S, Brown EJ and
Baltimore D: Germline transmission and tissue-specific expression
of transgenes delivered by lentiviral vectors. Science.
295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song X, Li L, Shi Q, Lehmler HJ, Fu J, Su
C, Xia X, Song E and Song Y: Polychlorinated biphenyl quinone
metabolite promotes p53-dependent DNA damage checkpoint activation,
S-Phase cycle arrest and extrinsic apoptosis in human liver
hepatocellular carcinoma HepG2 cells. Chem Res Toxicol.
28:2160–2169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fotedar A, Cannella D, Fitzgerald P,
Rousselle T, Gupta S, Dorée M and Fotedar R: Role for cyclin
A-dependent kinase in DNA replication in human S phase cell
extracts. J Biol Chem. 271:31627–31637. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guinn BA and Mulherkar R: International
progress in cancer gene therapy. Cancer Gene Ther. 15:765–775.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li W, Irani S, Crutchfield A, Hodge K,
Matthews W, Patel P, Zhang YJ and Stone E: Intramolecular cleavage
of the hASRGL1 homodimer occurs in two stages. Biochemistry.
55:960–969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saarela J, Laine M, Tikkanen R, Oinonen C,
Jalanko A, Rouvinen J and Peltonen L: Activation and
oligomerization of aspartylglucosaminidase. J Biol Chem.
273:25320–25328. 1998. View Article : Google Scholar : PubMed/NCBI
|
